Leonard John M.

President and CEO at NTLA; Director at IQV; Director at CHIMERIX INC, and 1 more

Sold, on record
$60.9M
Dollars the filings state
Form 4 sales
28
Latest Aug 21, 2026
Form 144 notices
0
Proposed sales
Companies
4
Filed as an executive or holder

Companies

  • NTLAIntellia Therapeutics, Inc.President and CEO
  • IQVIQVIA HOLDINGS INC.Director
  • CHIMERIX INCDirector
  • ABBVAbbVie Inc.SVP, Chief Scientific Officer

Sales by reason

2
Routine
0
Plan not stated
1
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale NTLAUnusual
    Sep 1, 2021 2021

    Sold 121,372 shares at $160.83 ($19.5M)

    Leonard John M, President and CEO

    Sold 14.4% of holdings ($135M position)719,305 shares left5.4x usual sizeFiling

  2. 2 Form 4 sale NTLAPlan not stated
    Jan 1, 2022 +122 days

    Sold 2,493 shares at $112.26 ($280k)

    Leonard John M, President and CEO

    Sold 0.3% of holdings ($81.6M position)724,660 shares left0.1x usual sizeFiling

  3. 3 Form 4 sale NTLAPlan not stated
    Jan 4, 2023 +368 days

    Sold 6,673 shares at $37.21 ($248k)

    Leonard John M, President and CEO

    Sold 0.9% of holdings ($28.8M position)766,825 shares left0.2x usual sizeFiling

  4. 4 Form 4 sale NTLANo plan
    Jan 3, 2024 +364 days

    Sold 19,223 shares at $29.46 ($566k)

    Leonard John M, President and CEO

    No 10b5-1 planSold 2.2% of holdings ($25.5M position)846,486 shares leftFiling

  5. 5 Form 4 sale NTLANo plan
    Jan 3, 2025 +366 days

    Sold 26,807 shares at $12.18 ($327k)

    Leonard John M, President and CEO

    No 10b5-1 planSold 2.8% of holdings ($11.8M position)941,115 shares leftFiling

  6. 6 Form 4 sale NTLARoutine
    Dec 11, 2025 +342 days

    Sold 88,146 shares at $9.49 ($836k)

    Leonard John M, President and CEO

    10b5-1 planSold 7.8% of holdings ($10.7M position)1M shares leftFiling

  7. 7 Form 4 sale NTLANo plan
    Jan 5, 2026 +25 days

    Sold 34,146 shares at $9.21 ($314k)

    Leonard John M, President and CEO

    No 10b5-1 planSold 3.3% of holdings ($9.6M position)1M shares leftFiling

  8. 8 Form 4 sale NTLARoutine
    Aug 21, 2026 +228 days

    Sold 22,675 shares at $12.65 ($287k)

    Leonard John M, President and CEO

    10b5-1 planSold 1.9% of holdings ($14.8M position)1.1M shares left0.7x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (28)

Form 144 notices and Form 4 sales by Leonard John M.
Source
Aug 21, 2026Aug 24, 2026NTLAPresident and CEOForm 4 sale22,675$287k1.9%RoutineSEC
Jan 5, 2026Jan 7, 2026NTLAPresident and CEOForm 4 sale34,146$314k3.3%No planSEC
Dec 11, 2025Dec 12, 2025NTLAPresident and CEOForm 4 sale88,146$836k7.8%RoutineSEC
Jan 3, 2025Jan 7, 2025NTLAPresident and CEOForm 4 sale26,807$327k2.8%No planSEC
Jan 3, 2024Jan 5, 2024NTLAPresident and CEOForm 4 sale19,223$566k2.2%No planSEC
Jan 4, 2023Jan 6, 2023NTLAPresident and CEOForm 4 sale6,673$248k0.9%Plan not statedSEC
Jan 1, 2022Mar 4, 2022NTLAPresident and CEOForm 4 sale2,493$280k0.3%Plan not statedSEC
Sep 1, 2021Sep 1, 2021NTLAPresident and CEOForm 4 sale121,372$19.5M14.4%UnusualSEC
Aug 23, 2021Aug 25, 2021NTLAPresident and CEOForm 4 sale27,139$4.1M3.6%Plan not statedSEC
Aug 19, 2021Aug 20, 2021NTLAPresident and CEOForm 4 sale22,682$3.4M3.1%Plan not statedSEC
Apr 1, 2021Apr 2, 2021NTLAPresident and CEOForm 4 sale38,209$3.2M5.2%Plan not statedSEC
Feb 9, 2021Feb 9, 2021NTLAPresident and CEOForm 4 sale50,985$3.7M7.2%UnusualSEC
Feb 3, 2021Feb 3, 2021NTLAPresident and CEOForm 4 sale177,745$12M22.4%UnusualSEC
Jan 5, 2021Jan 5, 2021NTLAPresident and CEOForm 4 sale6,239$349k1.3%Plan not statedSEC
Nov 27, 2020Nov 27, 2020NTLAPresident and CEOForm 4 sale35,000$1.4M7.0%UnusualSEC
Nov 25, 2020Nov 25, 2020NTLAPresident and CEOForm 4 sale50,000$1.8M9.7%UnusualSEC
Nov 16, 2020Nov 18, 2020NTLAPresident and CEOForm 4 sale20,000$680k4.1%UnusualSEC
Nov 4, 2020Nov 6, 2020NTLAPresident and CEOForm 4 sale50,000$1.3M9.7%UnusualSEC
Oct 7, 2020Oct 9, 2020NTLAPresident and CEOForm 4 sale5,000$109k1.1%Plan not statedSEC
Sep 1, 2020Sep 3, 2020NTLAPresident and CEOForm 4 sale5,000$109k1.1%Plan not statedSEC
Aug 6, 2020Aug 7, 2020NTLAPresident and CEOForm 4 sale5,000$109k1.1%Plan not statedSEC
Jul 1, 2020Jul 2, 2020NTLAPresident and CEOForm 4 sale5,000$109k1.1%Plan not statedSEC
Jun 3, 2020Jun 5, 2020NTLAPresident and CEOForm 4 sale5,000$109k1.1%Plan not statedSEC
Dec 20, 2019Dec 26, 2019IQVDirectorForm 4 sale20,200$3.1M71.0%UnusualSEC
May 14, 2018May 15, 2018NTLAPresident and CEOForm 4 sale8,400$202k100.0%UnusualSEC
Sep 15, 2016Sep 16, 2016CHIMERIX INCDirectorForm 4 sale5,000$25k100.0%UnusualSEC
Mar 15, 2013Mar 19, 2013ABBVSVP, Chief Scientific OfficerForm 4 sale46,700$1.8M30.3%UnusualSEC
Mar 8, 2013Mar 12, 2013ABBVSVP, Chief Scientific OfficerForm 4 sale27,949$1M20.7%Plan not statedSEC